Bronstein J M, Cliver S P, Goldenberg R L
University of Alabama at Birmingham (UAB), School of Public Health, Department of Health Care Organization and Policy 35294-2010, USA.
Health Serv Res. 1998 Feb;32(6):825-39.
To assess the relationship between clinical, demographic, and site-of-care factors and the use of tocolysis and corticosteroid therapy in the treatment of premature labor.
Secondary clinical and demographic data collected for the five-center March of Dimes Prematurity Prevention clinical trial, 1983-1986.
We used logistic regression analysis in assessing the clinical, patient, and care site factors associated with the use of tocolysis and corticosteroid therapy during episodes of premature labor occurring to women enrolled in the trial. The two interventions were not subject to control in the trial, but were provided according to customary practice at the care site.
A total of 4,625 episodes of labor occurring before 37 weeks gestation were identified from either preterm labor or preterm delivery records recorded for the 33,792 women enrolled in the trial.
The use of tocolysis, an intervention that attempts to control premature labor contractions and that was widely used in high-risk obstetrics, varied almost exclusively by clinical factors. The use of corticosteroid therapy, a little used but effective intervention that reduces respiratory complications in premature infants, varied significantly by site of care and was used less frequently across sites and clinical conditions for minority group patients.
This study confirms the premise that practice variation on the basis of nonclinical factors occurs more commonly for interventions where there is more uncertainty about clinical indications and effectiveness. The study also identifies another area of clinical care in which the use of aggressive and relatively uncertain interventions is provided less frequently to minority group patients.
评估临床、人口统计学及医疗场所因素与在早产治疗中使用宫缩抑制剂和皮质类固醇疗法之间的关系。
为1983 - 1986年开展的五中心“美国家产儿缺陷基金会早产预防”临床试验收集的二级临床和人口统计学数据。
我们采用逻辑回归分析来评估与试验中入组女性早产发作期间使用宫缩抑制剂和皮质类固醇疗法相关的临床、患者及医疗场所因素。这两种干预措施在试验中未设对照,而是根据医疗场所的惯常做法提供。
从试验中入组的33792名女性的早产或早产分娩记录中,共识别出4625例妊娠37周前的分娩发作。
宫缩抑制剂的使用,一种试图控制早产宫缩且在高危产科广泛使用的干预措施,几乎完全因临床因素而异。皮质类固醇疗法的使用,一种虽使用较少但能降低早产儿呼吸并发症的有效干预措施,因医疗场所不同而有显著差异,并且在不同场所和临床情况下,少数群体患者使用频率较低。
本研究证实了这样一个前提,即在临床适应症和有效性存在更多不确定性的干预措施中,基于非临床因素的实践差异更为常见。该研究还确定了临床护理的另一个领域,在这个领域中,少数群体患者较少接受积极且相对不确定的干预措施。